623PDA phase I and randomized phase II trial to evaluate...

623PDA phase I and randomized phase II trial to evaluate the efficacy and safety of nab-paclitaxel (nab-P) in combination with gemcitabine (G) for the treatment of patients with ECOG 2 advanced pancreatic cancer (PDAC)

Hidalgo, M., Pazo-Cid, R., Guillen-Ponce, C., López, R., Vera, R., Reboredo, M., Muñoz, A., Martinez de Castro, E., Díaz Beveridge, R., La Casta, A., Martin-Valades, J.I., Cubillo, A., Martínez-Galán,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx369.007
Date:
September, 2017
File:
PDF, 48 KB
english, 2017
Conversion to is in progress
Conversion to is failed